Loading clinical trials...
Loading clinical trials...
A Prospective Randomized Controlled Phase II Clinical Trial of Metformin in the Maintenance Therapy of High Risk Diffuse Large B Lymphoma / Stage III Follicular Lymphoma Patients With Complete Remission
Conditions
Interventions
Metformin
Placebos
Locations
1
China
Ruijin Hospital
Shanghai, China
Start Date
September 1, 2018
Primary Completion Date
January 1, 2021
Completion Date
December 1, 2021
Last Updated
March 11, 2020
NCT06528301
NCT02797470
NCT03293173
NCT02278796
NCT03744676
NCT05327725
Lead Sponsor
Ruijin Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions